In a latent infection with a Uganda clinical isolate (UgCl223), the proportion of CD8+ T-cells in the infected lung significantly decreased after week 1 of infection by approximately 20% but then remained unchanged over the course of 100 days [9]. Here, CD8A is linked to disease arising from reactivation of latent virus.